Migraine Trigger-Point / Peripheral Nerve Decompression Surgery | Proposed procedure and nerve risks

Migraine trigger-point surgery releases pressure on small sensory nerves and nearby vessels around the head. Trigger points are identified from your headache history and your ability to point to the pain; diagnostic numbing injections or botulinum toxin may help confirm them. Imaging or Doppler may also help locate compression points. Each site has a specific release: forehead muscle removal with possible nerve opening, temple nerve release, nasal septum or turbinate work, back-of-head nerve release with partial muscle removal, or vessel ligation. The exact plan depends on your symptoms, examination, and the trigger site identified; not every patient has all sites treated.

Migraine trigger-point surgery releases compressed sensory nerves around the head. Decompression aims to relieve pressure while preserving nerve function; nerve avulsion or transection, such as greater occipital nerve excision, can leave permanent numbness. Temporary paresthesia and anesthesia are the most common adverse consequences and are usually temporary. Transient sensation changes lasting up to one year are expected after surgery at all points and should be discussed beforehand. One report described permanent numbness at the temporal incision site in 5% of cases. Neuroma formation can also cause new pain after transection. The important trade-off is possible headache relief with possible lasting numbness.

Migraine trigger-point surgery releases pressure on sensory branches of trigeminal and occipital nerves at frontal, temporal, occipital, rhinogenic or nummular sites. It may involve decompression or, in some cases, avulsion of the offending nerve. Because nerves are handled, new pain can arise from neuroma formation or surgical injury; temporary sensation changes up to one year are expected. Site-specific complications such as scalp itching, hair loss, temporal hollowing, neck stiffness or nasal symptoms have been reported, but no neuroma rate is provided. The evidence describes overall safety and minimal complications, yet does not quantify painful neuroma risk. No specific neuroma incidence is reported in the cited evidence.

Anatomically, migraine surgery decompresses peripheral nerves at trigger sites. The corrugator supercilii, depressor supercilii and procerus relate to supraorbital and supratrochlear nerves, while the zygomaticotemporal branch and greater occipital nerve have their own muscular surroundings. Selective partial muscle resection or nerve avulsion can relieve compression. Because facial-expression muscles lie superficially and influence skin, surgical planning should respect them; complications remain site-specific, such as temporal hollowing, occipital neck stiffness or weakness, frontal scalp pruritus or alopecia. These are reported complications, not universal outcomes, and individual anatomy, trigger site and extent of decompression determine what is discussed before surgery. Selective partial resection aims to relieve nerve compression while preserving overall facial movement; exact muscle and extent vary by trigger site.

Migraine surgery is peripheral nerve decompression at identified trigger sites. In the forehead, nearby muscles can press on nerves above the eyebrows; in the back of the head, the greater occipital nerve passes through neck muscle. Greater occipital nerve decompression may involve lifting a fat flap. Surgery is offered only after appropriate selection. Trigger sites are confirmed before surgery with headache history, blocks, or botulinum toxin. Frontal nerves include the supraorbital and supratrochlear nerves; occipital nerves include the greater occipital nerve. Complications differ by site: forehead decompression has reported 9% scalp itching and 6% hair loss, while occipital decompression has a reported 12% risk of intermittent neck stiffness or weakness.

Each identified trigger point can be decompressed at known pressure points, either by direct nerve decompression or avulsion of the offending nerve. A patient with multiple trigger sites decompressed is among those more likely to have a good result. However, failed cases often show the primary trigger site was not properly assigned, meaning more than one trigger point contributed. Complications are site-specific: frontal decompression carries 9% scalp itching and 6% hair loss; temporal decompression 53% hollowing, 11% itching and 5% permanent numbness; occipital decompression 12% intermittent neck stiffness or weakness; rhinogenic decompression 19% nasal dryness, 18% runny nose, 5% sinus infection and 5% nosebleed. Intraoperative bleeding has been linked to worse outcomes.

Failure can occur when not all trigger sites are detected or surgery on a site is inadequate. In failed cases, the primary trigger site may not have been properly assigned, and more than one trigger point may contribute. After the dominant point is deactivated, other secondary points can become clinically evident. Anatomical overlap and small peripheral branch irritation can make localization difficult. A negative response to diagnostic injections does not definitively preclude surgery or predict failure. Success is often judged by at least a 50% decrease in migraine headache index, and some patients still do not respond despite all measures. Chronic migraine patients may have disrupted myelin sheaths or diffuse pain-pathway dysfunction, which may affect outcomes.

Migraine surgery releases pressure on sensory nerves at trigger points, but it is not a guaranteed cure. Accurate diagnosis comes first: a detailed headache history and examination with an established neurologist, plus confirmatory botulinum toxin or nerve blocks, help identify suitable trigger sites. Each identified trigger point can be decompressed by direct nerve decompression or avulsion. Reported complete symptom elimination varies widely, from 8.3% to 83% in one systematic review, with 35% to 57.1% in randomized trials; another review reported 68% to 95% success. Complications are site-specific, such as frontal scalp itching or hair loss, temporal hollowing, occipital neck stiffness, or nasal dryness. Surgery is usually reserved for symptoms not adequately controlled by medication or significant medication side effects.